Skip to main content
. 2024 Dec 4;40(1):138–147. doi: 10.1093/humrep/deae262

Table 3.

Fertility outcomes, pregnancy complications, and adult cardiovascular disease and diabetes type II according to menstrual cycle pattern in adolescence (15 years) and at age 38–40 years.

Adolescent menstrual cycle pattern
Regular
Oligomenorrhea
Adult menstrual cycle pattern
Regular Oligomenorrhea Regular Oligomenorrhea
Ado-adult subgroup REGREG REGOL OLREG OLOL

Fertility outcome

P-value

n=81

n=15

n=26

n=21

Subfertility >12 months 11 (14%) 6 (40.0%) 5 (19%) 7 (33%) 0.04
Fertility treatment (FT) 11 (14%) 3 (20%) 5 (19%) 9 (43%) 0.03
Ovulation disorder main reason for FT 3 (4%) 0 (0%) 2 (4%) 7 (33%) 0.001
Ovulation disorder mentioned.
as main or secondary reason for FT 3 (4%) 2 (13%) 2(4%) 7(33%) 0.003
Time to pregnancy—months mean (SD)*
6.5 (9.6)

17.4 (22.1)

12.6 (19.6)

13.9 (18.4)

0.05

Pregnancy complications


n=74

n=15

n=24

n=21

Pregnancy induced hypertension including pre-eclampia 13 (18%) 3 (20%) 4 (15%) 4 (19%) 0.98
Gestational diabetes 0 0 0 3 (15%) 0.001
Caesarean section
16 (22%)

3 (20%)

3 (12%)

4 (19%)

0.77

Cardiovascular disease and type 2 diabetes


n=93

n=15

n=31

n=21

Diabetes type II 1 (1%) 0 0 1 (5%) 0.44
High Cholesterol 3 (3%) 0 0 1 (5%) 0.62
Hypertension 3 (3%) 1 (6%) 2 (7%) 2 (9%) 0.62
Coronary or vascular disease 1 (1%) 0 0 0 0.89
Combined 6 (7%) 1 (6%) 2 (7%) 3(14%) 0.66
*

Those with infertility (no conception) excluded.

Data are presented as mean (SD) or number in subgroup (% in subgroup).

P-value for means: one-way ANOVA; P-value for proportions chi-square for multiple groups. Non-parametric Kruskal–Wallis test. Significant outcomes (P < 0.05) are presented in bold.